Join China Vaccine
Focus 2011

DAY 1, JUNE 9th
AM
Aligning Corporate Strategy with the Changing Vaccine Business Landscape
PM
Shaping Vaccine R&D Profitability
DAY 2, JUNE 10th
World Class Vaccine Bioprocessing, Production and Manufacturing
CVF2011-Where Global and Chinese Domestic Vaccine Giants Converge to Discuss Industry Redhots and New Business Opportunities
What do China’s "Twelfth Five-Year Plan" and new GMP regulation ring to domestic and foreign vaccine players? How to align vaccine development strategies with changing business landscape? Centered around the topic of "New GMP: Developing Safe, Reliable, High Yield Vaccines for a Healthier World ", CVF2011 will track various focus points on vaccines for infectious diseases, non-infectious diseases, AIDS vaccines, cancer vaccines, RNA/DNA vaccines, and point to the best opportunities for R&D partnering and manufacturing excellence. 

By the present of senior officials from Ministry of Health, PRC, SFDA/ FDA, NICPBP to address the latest regulatory issues on development of China vaccine industry.  Through two days’ various sessions such as keynote presentations, interactive panel discussions, case studies, cocktail party and scheduled one-to-one business meetings, you will hear the perspectives of both Chinese and MNC vaccine leaders. They will provide insights into their own company strategies for the coming years and how each perceives the marketplace developments. It will help you to win the vaccine market competition and strengthen your company’s dynamic growth in China’s vaccine market.

Distinguished Speakers Including:
Dr. Jean-Denis Shu
Medical Director
Sanofi Pasteur
Jin Yulan
President
Changchun
Biological Products Institute
Dr. Nicholas Jackson
Sr Director, Vaccine Research
Pfizer
Sam Liao
Asia Head of Business Development & Licensing
Novartis Vaccines & Diagnostics
Dr. Sean Du
Executive Director, Vaccine Research
Simcere Pharmaceutical
Dr. Li Shi
CEO
Shanghai Zerun Biotech Co., Ltd
Prof.Tim Hirst
Executive Chairman
Gamma Vaccines
James Zhao
Partner
Vivo Ventures
Dr. Aleš Štrancar
CEO
BIA Separations
Dr. Li Xiaoqiang
General Manager

TASLY & JENNER (Tianjin) Co., LTD
Li Bo
Director
National Institute for the Control of Pharmaceutical and Biological Products (NICPBP)
Shen Xinliang
Director-General

National Vaccine & Serum Institute & National Engineering Research Center for Novel Vaccines
Damian Thornton
Director,Business Development
M+W Group
Zheng Haifa
President
Beijing Minhai Biotechnology Co., Ltd

FEATURES of CVF 2011
Official Guideline Panel:
Official Guideline Panel is where senior officials from SFDA, FDA, CCDC and NICPBP will blueprint the clearer views on the updated government policies and development prospects of China's vaccine industry. You will have the unique chance to raise your concerns and have your burning questions answered.

R&D Focused Stream:
R&D Stream is where vaccine experts from pharmas and biotechs will discuss the latest vaccine
development in the industry. They will provide insights into their own company’s vaccine R&D strategies for the coming years and cover updates on adjuvants and delivery technologies for
vaccines.

Manufacturing Focused Stream:
Manufacturing Stream will address the new GMP compliance issue, safety evaluation and quality control over vaccines, and how to leverage on technology and equipment advancements for optimized vaccine bioprocessing and production.

Pre-scheduled One-to-One Meetings:
CDMC online partnering system allows you to easily pre-arrange meetings online with potential partners before coming to the forum, to have private conversations and to make deals on site.

Vaccine Service Exhibition:

An international exhibition of global vaccine fraternity to showcase their products, services and technologies.

FACTS & FIGURES
  • 300+ Attendees from global vaccine fraternity
  • 80+Pre-scheduled one-to-one meetings: CDMC online partnering system? allows you to easily pre-arrange meetings online with potential partners before coming to the forum, to have private conversations and to make deals on site.
  • 60+Chinese and international vaccine companies
  • 40+Presentations: High level vaccine executives share their knowledge and industry insights in keynote speeches and panels specifically oriented toward vaccine R&D and manufacturing.
  • 20Exhibitors: An international exhibition of global vaccine service companies showcasing their products and technologies.
  • 1Premium vaccine networking event in Asia

TESTIMONIALS:

WHO SHOULD ATTEND?

VIP Login
Copyright 2008 China Decision Makers Consultancy,All rights reserbved
T: +86 21 68407631 F: +86 21 68407633 | ICP08011529